Here’s whether Merck & Co., Inc. (MRK) is worth buying in 2026 —
based on weekly-updated price trend, RSI momentum, and return vs.
the S&P 500. Our current read: Bullish.
🟢
Bullish
Positives: trading above the 200-day MA (long-term uptrend intact); above the 50-day MA (medium-term momentum positive); 50-day MA is rising (+2.14% over 10 days); strong 1-year return of +64.1%; 3-month momentum positive (+22.0%). Currently 0.1% off its 52-week high. Score: +6/7.
MRK is in a confirmed uptrend, trading above both its 50-day ($125.48) and 200-day ($113.81) moving averages. An RSI of 66.9 sits in the neutral zone — momentum is neither stretched nor exhausted. The 1-year return of +64.1% compares to +20.4% for SPY (beat the market by 43.8%).
$10,000 invested 1 year ago→ $16,414 today
vs. S&P 500 (SPY) — same period beat market by 43.8%
1-Year Price Chart
Daily candles
MA-50MA-200UpDown
Signal Check
✓Above 200-day MA ($113.81)
✓Above 50-day MA ($125.48)
✓RSI(14) neutral zone (30–70) — currently 66.9
✓Positive return (+64.1%)
✓Within 10% of period high (−0.1%)
Period Range $135.84
$77.58$135.97
RSI (14) 66.9
0 · OversoldOverbought · 100
Key Metrics
Price$135.84
Period Return+64.1%
Period High$135.97
Period Low$77.58
Drawdown−0.1%
MA-50$125.48
MA-200$113.81
RSI (14)66.9
Avg Volume (30d)8.6M
vs. SPYbeat by 43.8%
Return Rank#239 of 1252
Trend Signals
Price is above the 200-day moving average ($113.81)
Price is above the 50-day moving average ($125.48)